MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein ingredient to its B2B partners.
MAASH has raised $6.8M in total funding. The most recent round was Seed. The last funding was announced in August 2026.
MAASH's investors include InvestPro, Bpifrance, Tereos, Nordzucker, Ambria Capital.
MAASH is headquartered in Anderlecht, Belgium.
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein ingredient to its B2B partners.
MAASH is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MAASH — Funding & Investors." VCBacked, August 26, 2026, https://www.vcbacked.co/company/maash. Accessed September 3, 2026.
VCBacked. (2026). MAASH — Funding & Investors. Retrieved September 3, 2026, from https://www.vcbacked.co/company/maash
{{cite web |title=MAASH — Funding & Investors |url=https://www.vcbacked.co/company/maash |website=VCBacked |access-date=September 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated